Compares two weight-loss surgeries for severe obesity
Compares two gastric bypass operations in adults with severe obesity over 10 years.
Plain-language title generated from the registry record
Registry title: RCT Comparing OAGB and Long Limb Roux Gastric Bypass
Key facts
- Where
- Tartu, EstoniaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT04812132, who can take part
Where in Estonia
- Tartu University HospitalTartu, EstoniaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tartu University Hospital
- Trial code
- NCT04812132
- Record updated
- 23 March 2021
- Original description
A prospective multicenter randomized controlled trial to compare the outcomes of one-anastomosis gastric bypass to long biliary limb Roux gastric bypass.Read full original descriptionShow less
A Multicentre Randomized Controlled Trial Comparing Outcome of Laparoscopic One-anastomosis Gastric Bypass and Laparoscopic Long Biliopancreatic Limb Roux Gastric Bypass for Treatment of Morbid Obesity.
A prospective multicenter randomized controlled trial to compare the outcomes of one-anastomosis gastric bypass to long biliary limb Roux gastric bypass.
We plan to enroll up to 500 patients from three different clinics in Estonia. Outcomes are excess weight loss %, impact on type 2 diabetes, hypertension, hyperlipidemia and obstructive sleep apnea.
Other outcomes are nutritional deficiencies, occurrence of reflux disease and impact on quality of life.
There are planned outpatient visits 1, 5 and 10 years after the surgery to measure the impacts.
There are a lot of studies comparing OAGB to standard Roux gastric bypass but non comparing it to long biliary limb gastric bypass.
Inclusion: BMI over 35 and obesity related disease; BMI over 40; age between 18-60 years; agrees to participate in the study.
Exclusion: abundant adhesions discovered during the surgery; prior bariatric surgery; active upper gastrointestinal ulcer disease; active symptomatic reflux disease; active psychiatric disease (eg psychosis); age under 18 years or over 60 years.